Search results for: therapy for emerging

Solicitation Details:TitleMultisystemic Therapy (MST) and Multisystemic Therapy for Emerging Adults (MST-EA) in Baltimore CityIDBPM031073Alternate IDLot #1Round #4StatusOpen[imp]OpenClosedResponses OpenedApprovedDraftDue / Close Date (EST)Due / Close Date (EST)Solicitation TypeRFP: Double Envelope ProposalPublic NoticePORFPRequest for Information & PricingRequest for InformationRequest for QuoteTechnical Envelope (Multi-Step)RFR - CATS SpecificFinancial

Current User: Home Biznet Menu Log In/Out Search Search Results Results Detail SCP Solicitation Details State Contracting Portal Solicitation Details Organization Children and Families, Department of Project/Solicitation # 190824004 Solicitation Type Request for Proposal Due Date 10/15/2018 Set-Aside NO Qualified Partnership NO Summary Multi-systemic Therapy for Emerging Adults Addenda RFP amendment to correct the language around number of proposal

Dates Award DateStart DateEnd Date10/29/201812/01/201806/30/2023 Description Transitional Supports for Emerging Adults. Comments Award Notification For Request for Proposal #190824004 Multi-Systemic Therapy for Emerging Adults (MST-EA).

See more details...

Contract Information: Contract Number: 3924 Contract Name: Multisystemic Therapy -Emerging Adult Treatment Services (MST-EA) Status: Active Attachment/Addendum(s) Addendum Addendum Addendum Vendor Information: NAFI Connecticut, Inc. Address: 20 Batterson Park Road, Suite 300 Farmington, CT 06032 Phone: 860-284-1177 Award Letter Date: 11/25/2019 Est.

UCF RESTORES’ unique approach to treatment – including the first-of-its-kind three-week intensive outpatient program – combines exposure therapy, emerging technology, one-on-one and group therapy sessions to realize unprecedented success for those suffering from PTSD.

for patients using emerging technologies; developing therapies, including vaccines, for prevention of CRC recurrence that are effective for minimal residual disease and adjuvant therapies irrespective of tumor mutational status; leveraging AI using existing large datasets and developing new datasets (molecular and clinical data) to advance precision medicine encompassing diagnostics, development of new treatments, treatment decisions, and longitudinal